At the C. elegans body wall neuromuscular junctions (NMJs) there are two cholinergic ionotropic receptor types, one that is heteromeric and activated by levamisole (LAChR) and one that is homomeric, alpha-7-like, and activated by nicotine (NAChR). Conserved components of a novel synaptic cleft scaffold have been implicated in the clustering of LAChRs, but the expression of the colocalized NAChR appears completely normal when these proteins are absent. This suggests that other, unidentified proteins regulate NAChR expression. The only receptor subunit known to be required for the C. elegans NAChR is ACR-16, which can form functional homo-pentameric receptors. A forward genetic screen was performed to isolate candidate genes involved in ACR-16 expression. The screen utilized a single-copy integrant of ACR-16::GFP to isolate mutants that decrease the synaptic level of ACR-16::GFP. From this screen a mutant was identified, and whole genome sequencing, using the Variant Density Mapping approach, revealed the sarcoplasmic reticulum calcium-ATPase
sca-1 as a likely candidate gene for this mutation. A
sca-1 reference mutant strain phenocopies the ACR-16::GFP expression defects. The expression and localization of LAChRs and inhibitory GABA receptors seem unaffected in a
sca-1 mutant background based on wild-type levels of LAChR::RFP and GABAR::GFP fluorescence. Behavioral assays show a more severe uncoordinated phenotype in a
sca-1;LAChR mutant background, consistent with an affect on ACR-16 receptors. The affects of
sca-1 on ACR-16 receptor function are not caused by defects in NMJ patterning, as there is no change in the number of synapses and muscle structure is wild type in these mutants. Electrophysiological recordings show a significant reduction in the evoked response of
sca-1 mutants suggesting a functional affect on the receptors. Responses to pressure-ejected nicotine in
sca-1 mutants are wild type implying that receptors are present on the muscle membrane but mislocalized. The reintroduction of SCA-1 driven by a muscle specific promoter is able to rescue the reduction in levels of ACR-16::GFP and the increased uncoordination seen in
sca-1;LAChR double mutants. Due to the role of SCA-1 in calcium level maintenance, calcium imaging was performed. In
sca-1 mutants there is a significant increase in baseline levels of calcium, however, stimulated calcium levels are significantly reduced as compared to the control. Preliminary calcium imaging in
acr-16 mutants suggests there is a similar phenotype to what is seen in
sca-1 mutants. This suggests a role for calcium homeostasis mediated through ACR-16 receptors. Further evaluation of this mechanism is on going.